Brokerages Set Addus HomeCare Co. (NASDAQ:ADUS) Price Target at $127.57

Shares of Addus HomeCare Co. (NASDAQ:ADUS) have been assigned a consensus rating of “Moderate Buy” from the eight ratings firms that are presently covering the stock, Marketbeat.com reports. One research analyst has rated the stock with a sell rating and seven have assigned a buy rating to the company. The average 1 year target price among brokerages that have issued ratings on the stock in the last year is $128.29.

A number of equities research analysts have weighed in on ADUS shares. Stephens reissued an “overweight” rating and set a $138.00 target price on shares of Addus HomeCare in a report on Tuesday, August 6th. TD Cowen lifted their price target on shares of Addus HomeCare from $128.00 to $137.00 and gave the stock a “buy” rating in a report on Thursday, August 8th. StockNews.com downgraded Addus HomeCare from a “strong-buy” rating to a “buy” rating in a report on Sunday, July 7th. Royal Bank of Canada reaffirmed an “outperform” rating and set a $141.00 target price on shares of Addus HomeCare in a report on Tuesday, September 3rd. Finally, Oppenheimer upped their price target on Addus HomeCare from $140.00 to $145.00 and gave the company an “outperform” rating in a research report on Monday, September 23rd.

Insider Activity at Addus HomeCare

In other Addus HomeCare news, EVP Michael D. Wattenbarger sold 21,917 shares of the business’s stock in a transaction that occurred on Monday, August 26th. The stock was sold at an average price of $133.29, for a total value of $2,921,316.93. Following the transaction, the executive vice president now directly owns 7,215 shares of the company’s stock, valued at $961,687.35. The sale was disclosed in a legal filing with the SEC, which is available through this link. In related news, Director Esteban Lopez sold 500 shares of the business’s stock in a transaction dated Wednesday, September 4th. The stock was sold at an average price of $130.03, for a total value of $65,015.00. Following the completion of the sale, the director now directly owns 3,866 shares of the company’s stock, valued at approximately $502,695.98. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, EVP Michael D. Wattenbarger sold 21,917 shares of the stock in a transaction that occurred on Monday, August 26th. The stock was sold at an average price of $133.29, for a total value of $2,921,316.93. Following the completion of the transaction, the executive vice president now owns 7,215 shares in the company, valued at approximately $961,687.35. The disclosure for this sale can be found here. Insiders have sold a total of 22,917 shares of company stock worth $3,050,082 in the last 90 days. Corporate insiders own 4.60% of the company’s stock.

Institutional Investors Weigh In On Addus HomeCare

Several hedge funds and other institutional investors have recently modified their holdings of the company. Charles Schwab Investment Management Inc. grew its position in Addus HomeCare by 7.4% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 179,635 shares of the company’s stock valued at $16,679,000 after purchasing an additional 12,392 shares during the period. Principal Securities Inc. bought a new position in shares of Addus HomeCare in the fourth quarter valued at $26,000. Dimensional Fund Advisors LP lifted its stake in shares of Addus HomeCare by 0.8% in the fourth quarter. Dimensional Fund Advisors LP now owns 698,498 shares of the company’s stock valued at $64,857,000 after buying an additional 5,654 shares in the last quarter. Envestnet Portfolio Solutions Inc. acquired a new position in shares of Addus HomeCare during the fourth quarter valued at about $214,000. Finally, Trexquant Investment LP bought a new stake in shares of Addus HomeCare during the fourth quarter worth about $271,000. Institutional investors own 95.35% of the company’s stock.

Addus HomeCare Stock Performance

Shares of ADUS opened at $130.95 on Monday. The stock has a market capitalization of $2.37 billion, a price-to-earnings ratio of 32.49, a PEG ratio of 2.40 and a beta of 1.04. Addus HomeCare has a 52 week low of $78.35 and a 52 week high of $136.12. The stock has a fifty day moving average of $128.25 and a 200-day moving average of $115.42.

Addus HomeCare (NASDAQ:ADUS) last announced its quarterly earnings results on Monday, August 5th. The company reported $1.35 EPS for the quarter, beating analysts’ consensus estimates of $1.21 by $0.14. Addus HomeCare had a return on equity of 9.81% and a net margin of 6.18%. The firm had revenue of $286.90 million for the quarter, compared to analyst estimates of $284.90 million. During the same period last year, the firm posted $0.94 earnings per share. The business’s revenue for the quarter was up 10.4% on a year-over-year basis. As a group, equities analysts forecast that Addus HomeCare will post 4.58 EPS for the current year.

Addus HomeCare Company Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.